ISSN 1612-3352

Editors in Chief

Prof. Dr. Claus F. Claussen, Neurootological Research Institute of the Research Society for Smell, Taste, Hearing and Equilibrium Disorders at Bad Kissingen (4-G-F). Bad Kissingen, Germany.
Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.

Production Managers

Dr. med. Julia M. Bergmann,
Dr. med. Guillermo O. Bertora,
Otoneuroophthalmological Neurophysiology,
Buenos Aires, Argentina.


Associated Editors


The editors welcome authors to submit articles for publications in the ASN.

Read the Information for Authors.


Kurhausstraße 12
D-97688 Bad Kissingen
Germany
Telefon +49-971-6 4832
Fax +49- 971- 6 8637
Email asn@neurootology.org

 

The role of free radicals and plasmatic antioxidant in menière syndrome

Abstract

The objective of this study is the supposition, verified through suitable hematochemical tests, of the co-presence in the etiopathogenesis of the Menière syndrome and/or in the labyrinth pathologies or hypacusia also of central/systemic microtoxicosis. We do not therefore exclude other well known hypotheses on the causality of these pathologies, but one finds, above all in the Menière cases, a constant homogeneous distribution of the metabolic products of this microtoxicosis, such as the presence of a high concentration of free radicals and low natural defences like the antioxidant plasmatic capacity. A kind therefore of dangerous central and systemic presence of reactive molecules towards the pufa and towards the homeostatic complex enzymes, not compensated for by the natural antioxidant defence.The certain presence of this lack of balance , verified by suitable tests, has shown the rationality of use of a product made from reduced glutathione, thioctic acid, cysteine and other antioxidants, as a multipurpose antidote towards this hypothesis of etiopathogenesis. Patients divided in three groups (control, conventional therapy and antioxidant treatment), have shown a net and more significant improvement in the gluta/tios group and above all in the Menière syndrome group. Also the parallel clinical and instrumental evaluations sustain this new therapeutic solution which, already positively demonstrated, will be the object of further evidence to support this primary hypothesis.

Login

Registration

If you are not already registered, please register here for free.

If you are registered but have forgotten your password (or you never had one), click here to recover your password.

Proceedings of

Authors

Archives

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |

(bi)gital»